Contact Information
For more information on the Rare Tumors Initiative or to become a member please contact:
Karlyne Reilly, Ph.D. Director, RTI and Head, Genetic Modifiers of Tumorigenesis Section, POB, CCR, NCI
- 301-846-7518
- reillyk@mail.nih.gov
Brigitte Widemann, M.D. Head, Pharmacology and Experimental Therapeutics Section, CCR, NCI
- 301-496-7387
- widemanb@nih.gov
Abby Sandler, Ph.D. Special Assistant to the Director, Rare Tumors Initiative, OD, CCR, NCI
- 301-496-9983
- sandlera@mail.nih.gov
Overview
Content Tools
ThemeBuilder